Packaging services provider Packaging Coordinators (PCI) has acquired pharmaceutical services provider Biotec for an undisclosed amount.
Headquartered in Wales, Biotec is a provider of clinical trials and temperature controlled pharmaceutical services.
The company said that this acquisition will help it expand its presence in the UK/EU region to support global investigational studies of medicinal products with the addition of packaging, storage and distribution capacity.
This investment will also help the company provide consultative services for clinical trial supplies.
Biotec recently undertook the expansion of its facilities. The company specializes in a range of projects across different temperature conditions including controlled room temperature, 2 - 8°C, -20°C, -40°C, -80°C, and specialization in products requiring -196°C.
These expansions helped the company quadruple its storage, packaging and shipping capacity. PCI also recently invested in a 93,000 ft2 North American Clinical Storage and Distribution facility, which includes storage for temperature controlled products of investigational products.
Apart from Biotec, PCI has made a series of acquisitions which include companies like Penn Pharma and AndersonBrecon. PCI operates about 16 facilities across North America and Europe with an employee base of over 2,900.
Speaking about the acquisition, PCI CEO and president Bill Mitchell said: "The expertise of the team at Biotec is a natural fit for the strategic direction of our business. We are focused on providing our clients an expert partner in the development, clinical investigation, and ultimate commercialization of their lifesaving therapies."
CEO of Biotec Services Fiona Withey added: "Joining the PCI family allows us to deliver a truly global service to our clients across a wider range of services, while staying true to our core values of expertise, customer service, efficiency and flexibility."
